ADIAL PHARMACEUTICALS, INC. (ADIL) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-13

ADIAL PHARMACEUTICALS, INC. (ADIL) has filed 4 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-13. 2 Form 8-K material event filings were reported by ADIL in the last 90 days. InsiderAlpha tracks every ADIL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About ADIAL PHARMACEUTICALS, INC. (ADIL)

SEC CIK	0001513525

90-Day SEC Filing Activity

Form 4 filings (90d)	4
Form 8-K filings (90d)	2
Latest Form 4 filing	2026-07-13

Recent ADIL Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-07-10	Coastlands Capital LP	10% Owner	P — Open-market purchase	1.7K	$2.70	$5K	SEC
2026-07-09	Coastlands Capital LP	10% Owner	P — Open-market purchase	10.1K	$2.79	$28K	SEC
2026-06-29	Coastlands Capital LP	10% Owner	P — Open-market purchase	25.0K	$2.60	$65K	SEC
2026-06-12	Davidson Matt	Chief Development Officer	A — Grant or award	232.4K	$0.00	—	SEC
2026-06-11	Davidson Matt	Chief Development Officer	A — Grant or award	3.4K	—	—	SEC
2026-06-11	Davidson Matt	Chief Development Officer	A — Grant or award	61.6K	—	—	SEC
2026-06-11	Davidson Matt	Chief Development Officer	A — Grant or award	1.8K	—	—	SEC
2026-06-11	Davidson Matt	Chief Development Officer	A — Grant or award	101	—	—	SEC
2026-04-07	Goodman Tony	Chief Operating Officer	A — Grant or award	26.5K	$0.00	—	SEC
2026-04-07	Claiborne Cary J	Chief Executive Officer	A — Grant or award	38.0K	$0.00	—	SEC
2026-04-07	Schuyler Kevin	Director	A — Grant or award	9.2K	$0.00	—	SEC
2026-04-07	Gilliland Robertson H.	Director	A — Grant or award	9.2K	$0.00	—	SEC
2026-04-07	Shah Vinay	Chief Financial Officer	A — Grant or award	17.3K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for ADIAL PHARMACEUTICALS, INC. (ADIL). Updated in real time as new filings are submitted to the SEC.

Most-Active ADIL Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Davidson Matt	6	—
Coastlands Capital LP	3	$98K
Young Wendy B.	1	$100K

Recent ADIL Form 8-K Material Events

2026-06-11 — Item 1.01, 2.01, 2.03, 3.02, 5.02, 5.03, 7.01, 9.01 [SEC]
2026-05-11 — Item 2.02, 9.01 [SEC]
2026-04-09 — Item 5.02, 9.01 · Leadership · neutral [SEC]
Adial Pharmaceuticals' Compensation Committee approved grants of restricted stock awards (RSAs) and stock options to named executive officers and directors on April 7, 2026. The grants include 37,985 RSAs to CEO Cary Claiborne, 17,325 RSAs to CFO Vinay Shah, 26,510 RSAs to COO To
2026-03-06 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Adial Pharmaceuticals issued a press release on March 6, 2026 reporting financial results for its fiscal year ended December 31, 2025. The filing provides standard annual financial information without explicit beat/miss language or forward guidance changes.
2026-03-03 — Item 7.01, 8.01, 9.01 · Contract · positive [SEC]
Adial Pharmaceuticals announced a collaboration framework agreement with Molteni Farmaceutici for exclusive European commercialization rights to AD04. The deal includes upfront and milestone payments plus tiered royalties (high single digits to low double digits), with total pote

Recent Insider Filings

2026-07-13 — Coastlands Capital LP (10% Owner)
2026-07-01 — Coastlands Capital LP (10% Owner)
2026-06-16 — Davidson Matt (Chief Development Officer)
2026-06-16 — Young Wendy B. (Director)
2026-04-09 — Goodman Tony (Chief Operating Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ADIL insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ADIL Insider Trading — FAQ

What is the latest insider trade for ADIL?: ADIAL PHARMACEUTICALS, INC. (ADIL) had 4 insider filings in the last 90 days, with the most recent on 2026-07-13. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ADIL stock?: 0 insider purchases of ADIL were filed in the last 90 days.
How many insiders are selling ADIL stock?: 0 insider sales of ADIL were filed in the last 90 days.
Where can I see ADIL SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ADIL SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ADIL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.